<VariationArchive VariationID="2953551" VariationName="NM_000083.3(CLCN1):c.1978del (p.Leu660fs)" VariationType="Deletion" Accession="VCV002953551" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3113652" VariationID="2953551">
      <GeneList>
        <Gene Symbol="CLCN1" FullName="chloride voltage-gated channel 1" GeneID="1180" HGNC_ID="HGNC:2019" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="143316111" stop="143352083" display_start="143316111" display_stop="143352083" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="143013218" stop="143049096" display_start="143013218" display_stop="143049096" Strand="+" />
          </Location>
          <OMIM>118425</OMIM>
        </Gene>
        <Gene Symbol="LOC123956257" FullName="Sharpr-MPRA regulatory region 4117" GeneID="123956257" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="143345416" stop="143345710" display_start="143345416" display_stop="143345710" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000083.3(CLCN1):c.1978del (p.Leu660fs)</Name>
      <CanonicalSPDI>NC_000007.14:143345565:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q34</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="143345566" stop="143345566" display_start="143345566" display_stop="143345566" variantLength="1" positionVCF="143345565" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="143042659" stop="143042659" display_start="143042659" display_stop="143042659" variantLength="1" positionVCF="143042658" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>L660fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.143042661del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.143042661del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.143345568del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.143345568del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009815.2" sequenceAccession="NG_009815" sequenceVersion="2" change="g.34443del">
            <Expression>NG_009815.2:g.34443del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_078448.1" sequenceAccession="NG_078448" sequenceVersion="1" change="g.253del">
            <Expression>NG_078448.1:g.253del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000083.3" sequenceAccession="NM_000083" sequenceVersion="3" change="c.1978del" MANESelect="true">
            <Expression>NM_000083.3:c.1978del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000074.3" sequenceAccession="NP_000074" sequenceVersion="3" change="p.Leu660fs">
            <Expression>NP_000074.3:p.Leu660fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046453.2" sequenceAccession="NR_046453" sequenceVersion="2" change="n.1933del">
            <Expression>NR_046453.2:n.1933del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000083.3(CLCN1):c.1978del (p.Leu660fs) AND multiple conditions" Accession="RCV003812774" Version="1">
        <ClassifiedConditionList TraitSetID="10487">
          <ClassifiedCondition DB="MedGen" ID="C2936781">Congenital myotonia, autosomal dominant form</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0751360">Congenital myotonia, autosomal recessive form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-29" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17932099</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22094069</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23739125</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10487" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5605" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thomsen disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thomsen's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal dominant form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+dominant/5073" DB="Genetic Alliance" />
                <XRef ID="57938005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">THD</ElementValue>
                <XRef Type="MIM" ID="160800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6176" />
                <XRef ID="6176" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C2936781" DB="MedGen" />
              <XRef ID="MONDO:0008055" DB="MONDO" />
              <XRef Type="MIM" ID="160800" DB="OMIM" />
            </Trait>
            <Trait ID="3015" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Myotonia congenita autosomal recessive</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotonia generalized</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker's disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Becker Generalized Myotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myotonia, autosomal recessive form</ElementValue>
                <XRef ID="Myotonia+congenita+autosomal+recessive/5074" DB="Genetic Alliance" />
                <XRef ID="20305008" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Myotonia congenita is characterized by muscle stiffness present from childhood; all striated muscle groups including the extrinsic eye muscles, facial muscles, and tongue may be involved. Stiffness is relieved by repeated contractions of the muscle (the "warm-up" phenomenon). Muscles are usually hypertrophic. Whereas autosomal recessive (AR) myotonia congenita is often associated with more severe manifestations (such as progressive minor distal weakness and attacks of transient weakness brought on by movement after rest), autosomal dominant (AD) myotonia congenita is not. The age of onset varies: in AD myotonia congenita onset is usually in infancy or early childhood; in AR myotonia congenita the average age of onset is slightly older. In both AR and AD myotonia congenita onset may be as late as the third or fourth decade of life.</Attribute>
                <XRef ID="NBK1355" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="844" />
                <XRef ID="844" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301529</ID>
                <ID Source="BookShelf">NBK1355</ID>
              </Citation>
              <Citation Type="general" Abbrev="EFNS, 2010">
                <ID Source="PubMed">20298421</ID>
              </Citation>
              <XRef ID="614" DB="Orphanet" />
              <XRef ID="C0751360" DB="MedGen" />
              <XRef ID="MONDO:0009715" DB="MONDO" />
              <XRef Type="MIM" ID="255700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8565434" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="29204494|MedGen:C0751360;C2936781" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004610883" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17932099</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22094069</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23739125</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu660Serfs*134) in the CLCN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CLCN1 are known to be pathogenic (PMID: 17932099, 22094069, 23739125). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CLCN1-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CLCN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.143042659del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0751360" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2936781" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8565434" TraitType="Disease" MappingType="XRef" MappingValue="C0751360" MappingRef="MedGen">
        <MedGen CUI="C0751360" Name="Congenital myotonia, autosomal recessive form" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8565434" TraitType="Disease" MappingType="XRef" MappingValue="C2936781" MappingRef="MedGen">
        <MedGen CUI="C2936781" Name="Congenital myotonia, autosomal dominant form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

